SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-044623
Filing Date
2023-04-12
Accepted
2023-04-12 16:35:41
Documents
14
Period of Report
2023-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2312468d1_8k.htm   iXBRL 8-K 39081
2 EXHIBIT 10.1 tm2312468d1_ex10-1.htm EX-10.1 93644
3 EXHIBIT 99.1 tm2312468d1_ex99-1.htm EX-99.1 16500
  Complete submission text file 0001104659-23-044623.txt   359382

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ganx-20230406.xsd EX-101.SCH 3057
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20230406_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20230406_pre.xml EX-101.PRE 22611
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2312468d1_8k_htm.xml XML 3708
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 23816096
SIC: 2834 Pharmaceutical Preparations